Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTC, ddI, and Efavirenz in Antiretroviral Naive HIV Infected Adults
NCT00196599Phase 2Completed
- Sponsor
- ANRS
- Start
- Feb 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emtricitabine, didanosine, efavirenz in human immunodeficiency virus infection (HIV), sponsored by ANRS. Started Feb 1999; status: completed.
02
Drugs
emtricitabinedidanosineefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00196599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00196599.